Drugs.com - Pharma Industry News

Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer

THURSDAY, Feb. 6, 2025 -- For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding nivolumab to neoadjuvant chemotherapy increases...

Feb 9, 2025 - 21:45
 0
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
THURSDAY, Feb. 6, 2025 -- For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding nivolumab to neoadjuvant chemotherapy increases...
Read More

Tags:

Previous Article

Weight Gain Common in Young Women After Breast Reduction Surgery

Next Article

HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia

Related Posts

2011 to 2023 Saw Increase in Early Adult Mortality in the United States

2011 to 2023 Saw Increase in Early Adult Mortality in t...

Feb 11, 2025  0

Smoking Linked to Cryptogenic Ischemic Stroke in Young Adults

Smoking Linked to Cryptogenic Ischemic Stroke in Young ...

Feb 24, 2025  0

ADHD Symptoms Linked to Onset of Nicotine, Tobacco Use in Youth

ADHD Symptoms Linked to Onset of Nicotine, Tobacco Use ...

Feb 14, 2025  0